JPM Thematics - Genetic Therapies C (dist) - USD
LU2309826514
JPM Thematics - Genetic Therapies C (dist) - USD/ LU2309826514 /
NAV30/05/2024 |
Var.+0.3500 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
56.5400USD |
+0.62% |
paying dividend |
Equity
Worldwide
|
JPMorgan AM (EU) ▶ |
Investment strategy
To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally.
Will invest in equities of companies that have been identified by the Investment Manager as being involved in research, development, production or marketing of genetic therapies and their associated businesses anywhere in the world, including emerging markets. The Investment Manager supervises and monitors the theme identification and portfolio construction process and actively selects securities for the Sub-Fund"s portfolio. At least 90% of companies purchased will be analysed against the theme.
Investment goal
To achieve a return by investing in companies with exposure to the theme of genetic therapies, globally.
Dati master
Type of yield: |
paying dividend |
Fondi Categoria: |
Equity |
Region: |
Worldwide |
Settore: |
Sector Health / Pharma |
Benchmark: |
MSCI All Country World Index (Total Return Net) |
Business year start: |
01/07 |
Ultima distribuzione: |
13/09/2023 |
Banca depositaria: |
J.P. Morgan SE - Zweigniederlassung Luxemburg |
Domicilio del fondo: |
Luxembourg |
Permesso di distribuzione: |
Austria, Germany, Switzerland, Luxembourg |
Gestore del fondo: |
Yazann Romahi, Aijaz Hussain |
Volume del fondo: |
588.01 mill.
USD
|
Data di lancio: |
10/03/2021 |
Investment focus: |
- |
Condizioni
Sovrapprezzo emissione: |
0.00% |
Tassa amministrativa massima: |
0.36% |
Investimento minimo: |
10,000,000.00 USD |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Prospetto semplificato: |
Download (Print version) |
Società d'investimento
Funds company: |
JPMorgan AM (EU) |
Indirizzo: |
PO Box 275, 2012, Luxembourg |
Paese: |
Luxembourg |
Internet: |
www.jpmorganassetmanagement.de
|
Attività
Stocks |
|
99.37% |
Mutual Funds |
|
0.63% |
Paesi
United States of America |
|
76.62% |
Switzerland |
|
8.07% |
Japan |
|
5.63% |
Germany |
|
2.30% |
Australia |
|
1.91% |
France |
|
1.31% |
China |
|
1.00% |
Taiwan, Province Of China |
|
0.72% |
Netherlands |
|
0.66% |
Korea, Republic Of |
|
0.62% |
Singapore |
|
0.32% |
United Kingdom |
|
0.24% |
Altri |
|
0.60% |
Filiali
Pharma/Biotechnology |
|
87.07% |
Healthcare services |
|
11.49% |
Healthcare appliances |
|
0.78% |
Altri |
|
0.66% |